Impact of Opioid Receptor, Mu 1 (OPRM1) Polymorphisms on Pain Sensitivity and Clinical Response to Opioid Analgesic Therapy

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 11, Iss. 1, 2013-03 ,pp. : 59-75

Bentham Science Publishers

Access to resources Recommend Favorite

CYP1A2, CYP2A6, CYP2B6, CYP3A4 and CYP3A5 Polymorphisms in Two Bantu-Speaking Populations from Cameroon and South Africa: Implications for Global Pharmacogenetics

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 10, Iss. 1, 2012-03 ,pp. : 43-53

Bentham Science Publishers

Access to resources Recommend Favorite

µ-opioid receptor gene variant OPRM1 118 A>G: a summary of its molecular and clinical consequences for pain

By Walter Carmen   Doehring Alexandra   Oertel Bruno G   Lötsch Jörn  

Pharmacogenomics, Vol. 14, Iss. 15, 2013-11 ,pp. : 1915-1925

Future Medicine

Access to resources Recommend Favorite

The Moderating Effect of Alcohol-Specific Parental Rule-Setting on the Relation between the Dopamine D2 Receptor Gene ( DRD2 ), the Mu-Opioid Receptor Gene ( OPRM1 ) and Alcohol Use in Young Adolescents

By Pieters Sara   Van Der Zwaluw Carmen S.   Van Der Vorst Haske   Wiers Reinout W.   Smeets Hubert   Lambrichs Ellen   Burk William J.   Engels Rutger C.M.E.  

Alcohol and Alcoholism, Vol. 47, Iss. 6, 2012-11 ,pp. : 663-670

Oxford University Press

Access to resources Recommend Favorite

Frequencies of Single Nucleotide Polymorphisms in Cytochrome P450 Genes (CYP1A2, 2A6, 2B6, 3A4 and 3A5) in a Rwandan Population: Difference to Other African Populations

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 11, Iss. 3, 2013-09 ,pp. : 237-246

Bentham Science Publishers

Access to resources Recommend Favorite